# Wound Healing Endpoint and Recurrence

> **NCT02577120** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sashwati Roy** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Wound
- Burn Wound
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Chronic
- Wound

## Interventions

- **DEVICE:** Epiceram Skin Barrier Function
- **BIOLOGICAL:** Vaseline Petroleum Jelly

## Key facts

- **NCT ID:** NCT02577120
- **Lead sponsor:** Sashwati Roy
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-08
- **Primary completion:** 2029-02
- **Final completion:** 2034-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02577120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02577120, "Wound Healing Endpoint and Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02577120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*